Aldeyra reports positive top-line data from Phase 2 reproxalap study in dry eye disease
12 January 2022 - 12:38AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
From Apr 2023 to Apr 2024